189 related articles for article (PubMed ID: 16126325)
1. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer.
Delongchamps NB; Mao K; Theng H; Zerbib M; Debré B; Peyromaure M
Eur Urol; 2005 Dec; 48(6):946-50. PubMed ID: 16126325
[TBL] [Abstract][Full Text] [Related]
2. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
[TBL] [Abstract][Full Text] [Related]
3. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.
Pignot G; Salomon L; Neuzillet Y; Masson-Lecomte A; Lebacle C; Patard JJ; Lunardi P; Rischmann P; Pasticier G; Bernhard JC; Cohen J; Timsit MO; Verkarre V; Peyronnet B; Verhoest G; Le Goux C; Zerbib M; Brecheteau F; Bigot P; Larre S; Murez T; Thuret R; Lacarriere E; Champy C; Roupret M; Comperat E; Berger J; Descazeaud A; Toledano H; Bastide C; Lavilledieu S; Avances C; Delage F; Valeri A; Molimard B; Houlgatte A; Gres P; Donnaint A; Kleinclauss F; Legal S; Doerfler A; Koutlidis N; Cormier L; Hetet JF; Colls P; Arvin-Berod A; Rambeaud JJ; Quintens H; Soulie M; Pfister C;
Ann Surg Oncol; 2014 Feb; 21(2):684-90. PubMed ID: 24170436
[TBL] [Abstract][Full Text] [Related]
5. Incidental prostate cancer in radical cystoprostatectomy specimens.
Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
Pettus JA; Al-Ahmadie H; Barocas DA; Koppie TM; Herr H; Donat SM; Dalbagni G; Reuter VE; Olgac S; Bochner BH
Eur Urol; 2008 Feb; 53(2):370-5. PubMed ID: 17689003
[TBL] [Abstract][Full Text] [Related]
7. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
Weizer AZ; Shah RB; Lee CT; Gilbert SM; Daignault S; Montie JE; Wood DP
Urol Oncol; 2007; 25(6):460-4. PubMed ID: 18047952
[TBL] [Abstract][Full Text] [Related]
9. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
Hemal AK; Kolla SB
J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
[TBL] [Abstract][Full Text] [Related]
10. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
[TBL] [Abstract][Full Text] [Related]
12. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
13. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.
Abdelhady M; Abusamra A; Pautler SE; Chin JL; Izawa JI
BJU Int; 2007 Feb; 99(2):326-9. PubMed ID: 17026595
[TBL] [Abstract][Full Text] [Related]
14. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.
Damiano R; Di Lorenzo G; Cantiello F; De Sio M; Perdonà S; D'Armiento M; Autorino R
Eur Urol; 2007 Sep; 52(3):648-57. PubMed ID: 17600614
[TBL] [Abstract][Full Text] [Related]
16. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy.
Inman BA; DiMarco DS; Slezak JM; Sebo TJ; Kwon ED; Leibovich BC; Blute ML; Zincke H
Urology; 2006 Sep; 68(3):604-8. PubMed ID: 16979719
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
[TBL] [Abstract][Full Text] [Related]
19. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
[TBL] [Abstract][Full Text] [Related]
20. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
